Brinker Capital’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | $3.49M | Buy |
50,437
+373
| +0.7% | +$25.8K | 0.11% | 188 |
|
|
2020
Q1 | $3.15M | Sell |
50,064
-9,537
| -16% | -$600K | 0.13% | 168 |
|
|
2019
Q4 | $4.64M | Sell |
59,601
-936
| -2% | -$72.8K | 0.14% | 149 |
|
|
2019
Q3 | $4.44M | Sell |
60,537
-5,520
| -8% | -$405K | 0.15% | 143 |
|
|
2019
Q2 | $4.07M | Sell |
66,057
-2,283
| -3% | -$141K | 0.15% | 142 |
|
|
2019
Q1 | $4.36M | Sell |
68,340
-381
| -0.6% | -$24.3K | 0.17% | 136 |
|
|
2018
Q4 | $3.51M | Sell |
68,721
-7,635
| -10% | -$390K | 0.16% | 137 |
|
|
2018
Q3 | $4.43M | Buy |
76,356
+2,493
| +3% | +$145K | 0.16% | 139 |
|
|
2018
Q2 | $3.58M | Sell |
73,863
-6,888
| -9% | -$334K | 0.14% | 153 |
|
|
2018
Q1 | $3.76M | Buy |
80,751
+10,530
| +15% | +$490K | 0.15% | 146 |
|
|
2017
Q4 | $2.64M | Buy |
70,221
+6,387
| +10% | +$240K | 0.1% | 203 |
|
|
2017
Q3 | $2.33M | Buy |
63,834
+120
| +0.2% | +$4.37K | 0.1% | 211 |
|
|
2017
Q2 | $2.51M | Buy |
63,714
+1,824
| +3% | +$71.9K | 0.12% | 194 |
|
|
2017
Q1 | $1.94M | Buy |
61,890
+22,497
| +57% | +$706K | 0.09% | 223 |
|
|
2016
Q4 | $1.23M | Buy |
39,393
+23,775
| +152% | +$742K | 0.07% | 254 |
|
|
2016
Q3 | $628K | Sell |
15,618
-2,313
| -13% | -$93K | 0.06% | 147 |
|
|
2016
Q2 | $596K | Buy |
17,931
+381
| +2% | +$12.7K | 0.05% | 162 |
|
|
2016
Q1 | $516K | Buy |
17,550
+2,850
| +19% | +$83.8K | 0.04% | 192 |
|
|
2015
Q4 | $387K | Buy |
+14,700
| New | +$387K | 0.03% | 175 |
|